Richard Goodwin

536 total citations
7 papers, 376 citations indexed

About

Richard Goodwin is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Richard Goodwin has authored 7 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Pharmacology. Recurrent topics in Richard Goodwin's work include Neurotransmitter Receptor Influence on Behavior (3 papers), Receptor Mechanisms and Signaling (2 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Richard Goodwin is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (3 papers), Receptor Mechanisms and Signaling (2 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Richard Goodwin collaborates with scholars based in United Kingdom, India and Australia. Richard Goodwin's co-authors include Fiona Thomson, Glenn Walker, Phillip M. Cowley, Lesley Stevenson, Lorraine McIntosh, Adèle Thomas, Arthur Christopoulos, Roger G. Pertwee, Gillian Goodwin and Julia Marrs and has published in prestigious journals such as The FASEB Journal, Molecular Pharmacology and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Richard Goodwin

7 papers receiving 362 citations

Peers

Richard Goodwin
Paul Westwood United Kingdom
Gillian Goodwin United Kingdom
Lorraine McIntosh United Kingdom
Thuy Nguyen United States
Avgui Charalambous United States
Phillip M. Cowley United Kingdom
Amanda J. Wheal United Kingdom
Robert P. Picone United States
Donna J. Fournier United States
Paul Westwood United Kingdom
Richard Goodwin
Citations per year, relative to Richard Goodwin Richard Goodwin (= 1×) peers Paul Westwood

Countries citing papers authored by Richard Goodwin

Since Specialization
Citations

This map shows the geographic impact of Richard Goodwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Goodwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Goodwin more than expected).

Fields of papers citing papers by Richard Goodwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Goodwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Goodwin. The network helps show where Richard Goodwin may publish in the future.

Co-authorship network of co-authors of Richard Goodwin

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Goodwin. A scholar is included among the top collaborators of Richard Goodwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Goodwin. Richard Goodwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Gupta, Anshul, Natalie Keirstead, Harish Shankaran, et al.. (2015). Toxicokinetic Insights are Critical to Understanding Renal Toxicity of Novel Polymyxin Analog. The FASEB Journal. 29(S1). 1 indexed citations
2.
Baker, James Α., Matilda Bingham, Angus R. Brown, et al.. (2011). Optimisation of pharmacokinetic properties to afford an orally bioavailable and selective V1A receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 21(15). 4622–4628. 2 indexed citations
3.
Reid, Mark, Wilson Caulfield, Ola Epemolu, et al.. (2010). The discovery and SAR of indoline-3-carboxamides—A new series of 5-HT6 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(12). 3713–3716. 6 indexed citations
4.
Cowley, Phillip M., James Α. Baker, John K. Clark, et al.. (2010). The discovery of novel indole-2-carboxamides as cannabinoid CB1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(1). 497–501. 6 indexed citations
5.
Bingham, Matilda, Richard Goodwin, Anders Haunsø, et al.. (2010). The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain. Bioorganic & Medicinal Chemistry Letters. 21(1). 271–275. 3 indexed citations
6.
Baillie, Gemma L., Adèle Thomas, Lesley Stevenson, et al.. (2005). Allosteric Modulation of the Cannabinoid CB1 Receptor. Molecular Pharmacology. 68(5). 1484–1495. 348 indexed citations
7.
Palin, Ronald, John K. Clark, Jean E. Cottney, et al.. (2004). Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonists. Bioorganic & Medicinal Chemistry Letters. 15(3). 589–593. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026